Market Research Report
EUROPE DRUG DISCOVERY MARKET FORECAST 2018-2026
|Published by||Inkwood Research||Product code||609208|
|Published||Content info||88 Pages
Delivery time: 1-2 business days
|EUROPE DRUG DISCOVERY MARKET FORECAST 2018-2026|
|Published: March 2, 2018||Content info: 88 Pages||
The European drug discovery market is set to grow at an impresive rate over the forecast period of 2018-2026. This essentail healthcare market is anticipated to rise at with a 9.33% CAGR.
The European healthcare market is equipped with comprehensive and updated technology. Also, the healthcare spending of European countries is increasing considerably. The U.K drug discovery market accounted for the most significant revenue share in 2017. Other significant contributors included Germany, France, Spain, Italy and rest of Europe. Implementation of drug discovery programs across these regions is boosting the market demand. However, stringent government regulations delaying the processes for product launches could significantly restrain the market growth.
Boehringer Ingelheim, GlaxoSmithKline Llc, Bayer Ag, F. Hoffmann-La Roche Ltd, Sanofi, Eli Lily, Pfizer Inc, AstraZeneca Plc and Merck & Co. Inc are few of the established players in this market.